Über Artivion, Inc. Common Stock Unternehmensübersicht von Wikipedia

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

## History

Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.

In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.

In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.

In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.

In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.

In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.

In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

AORT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs

$28.89

Marktkapitalisierung

$1.44B

P/E (TTM)

139.4

EPS (TTM)

$0.21

Umsatz (TTM)

$441M

Dividendenrendite

—

ROE

2.2%

Verschuldungsgrad

0.5

52W-Spanne

$19 – $48

AORT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $441M

2016-12-31 → 2025-12-31

EPS $0.21

2016-12-31 → 2025-12-31

Freier Cashflow $839.0K

2016-12-31 → 2025-12-31

Margen 2.2%

2016-12-31 → 2025-12-31

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl

5-Jahres-Trend

AORT

Peer-Median

P/E (TTM)

139.4

38.5

P/S (TTM) (K/V (TTM))

3.3

2.5

P/B (K/B)

3.2

4.8

EV / EBITDA

28.4

—

Price / FCF (Kurs / FCF)

1720.8

—

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl

5-Jahres-Trend

AORT

Peer-Median

Gross Margin (Bruttogewinnmarge)

64.4%

58.7%

Operating Margin (Betriebsgewinnmarge)

7.6%

—

Net Profit Margin (Nettogewinnmarge)

2.2%

-12.6%

ROA

1.2%

-11.8%

ROE

2.2%

-37.7%

ROIC

3.4%

—

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl

5-Jahres-Trend

AORT

Peer-Median

Debt / Equity (Fremdkapital / Eigenkapital)

0.5

25.5

Current Ratio (Liquiditätsgrad)

3.5

Quick Ratio

1.5

—

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl

5-Jahres-Trend

AORT

Peer-Median

Revenue YoY (Umsatz YoY)

13.6%

—

Revenue CAGR 3Y (Umsatz CAGR 3J)

12.0%

—

Revenue CAGR 5Y (Umsatz CAGR 5J)

11.8%

—

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl

5-Jahres-Trend

AORT

Peer-Median

EPS (Diluted) (EPS (Verwässert))

$0.21

—

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl

5-Jahres-Trend

AORT

Peer-Median

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

Dividendenrendite

—

Ausschüttungsquote

—

5J Div CAGR

—

Ex-Datum	Betrag
9. Dezember 2015	$0,0300
9. September 2015	$0,0300
10. Juni 2015	$0,0300
11. März 2015	$0,0300
10. Dezember 2014	$0,0300
10. September 2014	$0,0300
11. Juni 2014	$0,0300
12. März 2014	$0,0280
11. Dezember 2013	$0,0280
11. September 2013	$0,0280
12. Juni 2013	$0,0280
12. März 2013	$0,0250
12. Dezember 2012	$0,0250
12. September 2012	$0,0250

AORT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 14 Analysten

Starker Kauf 5 35,7%
Kauf 8 57,1%
Halten 1 7,1%
Verkauf 0 0,0%
Starker Verkauf 0 0,0%

12-Monats-Kursziel

8 Analysten · 2026-08-18

Median $42.00

← Unter allen Zielen $28.89

Tief $38.00

Hoch $48.00

Median-Ziel $42.00 +45,4%

Mittelwert-Ziel $42.15 +45,9%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung

-0.02%

Zeitraum	EPS Actual	EPS est.	Überraschung
30. Juni 2026	$-0.28	$0.01	-0.29%
31. März 2026	$0.03	$0.05	-0.02%
31. Dezember 2025	$0.05	$0.08	-0.03%
30. September 2025	$0.06	$0.02	0.04%
30. Juni 2025	$0.08	$-0.00	0.08%
31. März 2025	$-0.01	$-0.12	0.11%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker	Marktkapitalisierung	P/E	Umsatz Vj.	Nettomarge	ROE	Bruttogewinnmarge
AORT	$2.25B	217.2	13.6%	2.2%	2.2%	64.4%
TNDM	$1.50B	-7.2	7.9%	-20.2%	-141.9%	53.8%
CNMD	$1.27B	26.9	5.2%	3.4%	4.6%	54.6%
ATEC	$3.16B	-21.9	24.9%	-18.8%	-792.1%	69.6%
ENOV	$1.52B	-1.3	6.7%	-52.7%	-58.5%	59.8%
IART	—	-1.8	1.5%	-31.6%	-49.6%	—
KMTS	$1.21B	-8.5	59.0%	-138.4%	-62.1%	51.4%
PRCT	$1.77B	-18.3	37.2%	-31.0%	-25.4%	63.7%
IRMD	$1.24B	55.6	14.4%	26.8%	23.8%	76.8%
ABT	$250.18B	33.7	5.7%	14.7%	13.1%	—

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 18

Jährliche Gewinn- und Verlustrechnung-Daten für AORT
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$441M	$389M	$354M	$314M	$299M	$253M	$276M	$263M	$190M	$180M	$146M	$145M
Cost of Revenue	$157M	$140M	$125M	$111M	$101M	$85M	$93M	$90M	$61M	$61M	$55M	$53M
Gross Profit	$284M	$249M	$229M	$203M	$198M	$168M	$183M	$173M	$129M	$119M	$91M	$91M
R&D Expense	$31M	$28M	$29M	$39M	$36M	$24M	$23M	$23M	$19M	$13M	$10M	$9M
SG&A Expense	$226M	$181M	$209M	$157M	$170M	$141M	$143M	$141M	$101M	$92M	$75M	$74M
Operating Expenses	$257M	$210M	$238M	$196M	$205M	$165M	$166M	$164M	$121M	$105M	$85M	$82M
Operating Income	$34M	$39M	$6M	$6M	$8M	$2M	$17M	$9M	$8M	$22M	$5M	$9M
Interest Expense	·	·	$25M	$18M	$17M	$17M	$15M	$16M	$5M	$3M	$62.0K	$175.0K
Interest Income	$763.0K	$1M	$1M	$147.0K	$79.0K	$217.0K	$738.0K	$226.0K	$212.0K	$72.0K	$45.0K	$50.0K
Other Non-op	$10M	$-10M	$-3M	$-3M	$-6M	$-3M	$-1M	$-141.0K	$260.0K	$-437.0K	$-484.0K	$-540.0K
Pretax Income	$15M	$-8M	$-22M	$-15M	$-15M	$-17M	$2M	$-6M	$4M	$18M	$6M	$9M
Income Tax	$5M	$6M	$9M	$4M	$7.0K	$-492.0K	$-76.0K	$-4M	$-143.0K	$8M	$2M	$1M
Net Income	$10M	$-13M	$-31M	$-19M	$-15M	$-17M	$2M	$-3M	$4M	$11M	$4M	$7M
EPS (Basic)	$0.22	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.33	$0.14	$0.26
EPS (Diluted)	$0.21	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.32	$0.14	$0.25
Shares (Basic)	45,335,000	41,676,000	40,743,000	40,032,000	38,983,000	37,861,000	37,118,000	36,412,000	33,008,000	31,855,000	27,744,000	27,379,000
Shares (Diluted)	47,162,000	41,676,000	40,743,000	40,032,000	38,983,000	37,861,000	37,860,000	36,412,000	34,163,000	32,822,000	28,542,000	28,313,000
EBITDA	$56M	$63M	$29M	$29M	$32M	$23M	$35M	$27M	$18M	$30M	·	$15M

Bilanz 28

Jährliche Bilanz-Daten für AORT
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$65M	$53M	$59M	$39M	$55M	$61M	$34M	$41M	$40M	$57M	$38M	$33M
Receivables	$90M	$79M	$72M	$62M	$53M	$46M	$53M	$47M	$48M	$28M	$23M	$21M
Inventory	$92M	$80M	$82M	$74M	$77M	$73M	$53M	$45M	$47M	$26M	$15M	$13M
Prepaid Expense	$43M	$19M	$16M	$18M	$15M	$14M	$12M	$7M	$5M	$3M	$5M	$5M
Current Assets	$358M	$290M	$281M	$247M	$248M	$235M	$187M	$179M	$179M	$147M	$110M	$106M
PP&E (Net)	$65M	$36M	$38M	$39M	$38M	$33M	$32M	$31M	$34M	$19M	$11M	$12M
PP&E (Gross)	·	·	·	$127M	$120M	$111M	$103M	$96M	$93M	$74M	$64M	$62M
Accum. Depreciation	·	·	·	$88M	$82M	$78M	$71M	$65M	$60M	$55M	$53M	$50M
Goodwill	$254M	$241M	$247M	$244M	$250M	$260M	$187M	$189M	$188M	$78M	$11M	$11M
Intangibles	$124M	$128M	$143M	$151M	$167M	$186M	$115M	$118M	$130M	$1M	$1M	$2M
Other Non-current Assets	$15M	$24M	$9M	$7M	$8M	$15M	$14M	$8M	$7M	$2M	$6M	$5M
Total Assets	$885M	$789M	$792M	$763M	$793M	$789M	$606M	$571M	$590M	$316M	$181M	$176M
Accounts Payable	$16M	$18M	$13M	$12M	$10M	$10M	$10M	$8M	$10M	$6M	$5M	$4M
Accrued Liabilities	$16M	$12M	$10M	$12M	$8M	$7M	$7M	$7M	$12M	$5M	$3M	$3M
Current Liabilities	$102M	$67M	$58M	$50M	$45M	$60M	$45M	$35M	$43M	$30M	$20M	$21M
Capital Leases	$34M	$40M	$44M	$41M	$45M	$14M	$18M	$0	$7M	$11.0K	·	·
Deferred Tax	$24M	$20M	$22M	$24M	$29M	$35M	$26M	$27M	$30M	$7.0K	·	·
Other Non-current Liabilities	$9M	$8M	$7M	$7M	$6M	$7M	$7M	$7M	$8M	$5M	$3M	$3M
Total Liabilities	$437M	$513M	$511M	$478M	$492M	$461M	$320M	$296M	$313M	$107M	$26M	$27M
Long-term Debt	$215M	$314M	$307M	$308M	$309M	$292M	$216M	$217M	$219M	$72M	·	·
Total Debt	$215M	$314M	$307M	$308M	$309M	$292M	$216M	$217M	$219M	$72M	·	·
Common Stock	$493.0K	$434.0K	$426.0K	$418.0K	$414.0K	$404.0K	$390.0K	$385.0K	$376.0K	$342.0K	$298.0K	$292.0K
Retained Earnings	$-51M	$-61M	$-48M	$-17M	$2M	$20M	$37M	$35M	$38M	$34M	$23M	$23M
Treasury Stock	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$13M	$12M	$11M	$9M
AOCI	$-3M	$-25M	$-12M	$-22M	$-10M	$7M	$-9M	$-6M	$2M	$-429.0K	$-76.0K	$-121.0K
Stockholders' Equity	$448M	$276M	$282M	$284M	$301M	$329M	$286M	$275M	$277M	$209M	$155M	$149M
Liabilities + Equity	$885M	$789M	$792M	$763M	$793M	$789M	$606M	$571M	$590M	$316M	$181M	$176M
Shares Outstanding	49,330,000	43,432,000	42,569,000	41,830,000	41,397,000	40,394,000	39,018,000	38,463,000	37,618,000	34,230,000	29,766,000	29,229,000

Cashflow 19

Jährliche Cashflow-Daten für AORT
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$22M	$24M	$23M	$22M	$24M	$21M	$18M	$18M	$10M	$8M	$6M	$6M
Stock-based Comp	$24M	$14M	$14M	$12M	$11M	$7M	$9M	$6M	$7M	$6M	$5M	$3M
Deferred Tax	$37.0K	$-2M	$-1M	$-885.0K	$-6M	$816.0K	$-2M	$-6M	$-1M	$3M	$1M	$173.0K
Amort. of Intangibles	$14M	$16M	$15M	$15M	$17M	$14M	$11M	$11M	$5M	$4M	$2M	$2M
Other Non-cash	$-17M	$-1M	$13M	$-20M	$-17M	$611.0K	$-11M	$-5M	$-8M	$-8M	·	$-9M
Operating Cash Flow	$40M	$22M	$19M	$-5M	$-3M	$12M	$16M	$10M	$11M	$20M	$11M	$8M
CapEx	$39M	$11M	$10M	$11M	$13M	$7M	$8M	$6M	$7M	$6M	$3M	$4M
Investing Cash Flow	$-42M	$-28M	$-502.0K	$-11M	$6M	$-73M	$-24M	$-7M	$-171M	$-79M	$-4M	·
Debt Issued	$0	$184M	$0	$0	·	·	·	·	·	·	·	·
Net Debt Issued	$-210.0K	$-28M	$-3M	·	·	·	·	·	·	·	·	·
Stock Issued	$13M	$6M	$4M	$3M	$4M	$2M	$5M	$4M	$3M	$2M	$2M	$3M
Stock Repurchased	·	·	·	·	·	·	·	·	·	·	·	$6M
Net Stock Activity	$13M	$6M	$4M	$3M	$4M	$2M	$5M	$4M	$3M	$2M	·	$-3M
Dividends Paid	·	·	·	·	·	·	·	·	·	·	$3M	$3M
Financing Cash Flow	$11M	$2M	$865.0K	$-2M	$-12M	$94M	$-1M	$-3M	$143M	$73M	$-3M	·
Net Change in Cash	$11M	$-5M	$20M	$-16M	$-7M	$28M	$-8M	$1M	$-17M	$14M	$4M	$-4M
Taxes Paid	$3M	·	·	·	·	·	·	·	·	·	$145.0K	$3M
Free Cash Flow	$839.0K	$11M	$11M	$-14M	$-16M	$5M	$8M	$4M	$4M	$14M	·	$4M
Levered FCF	·	·	$-25M	$-38M	$-33M	$-11M	$-8M	$-3M	$-925.8K	$12M	·	·

Rentabilität 8

Jährliche Rentabilität-Daten für AORT
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	64.4%	64.0%	64.7%	64.5%	66.1%	66.3%	66.3%	65.8%	67.8%	65.9%	·	63.1%
Operating Margin	7.6%	10.0%	1.6%	2.0%	2.7%	0.96%	6.2%	3.5%	4.2%	12.1%	·	6.1%
Net Margin	2.2%	-3.4%	-8.7%	-6.1%	-5.0%	-6.6%	0.62%	-1.1%	1.9%	6.0%	·	5.1%
Pretax Margin	3.4%	-1.9%	-6.1%	-4.8%	-5.0%	-6.8%	0.60%	-2.4%	1.9%	10.2%	·	6.0%
EBITDA Margin	12.7%	16.2%	8.1%	9.1%	10.7%	9.1%	12.8%	10.4%	9.3%	16.7%	·	10.3%
ROA	1.2%	-1.7%	-4.0%	-2.5%	-1.9%	-2.4%	0.29%	-0.49%	0.82%	4.3%	·	4.2%
ROE	2.2%	-4.6%	-11.1%	-7.1%	-4.9%	-5.1%	0.61%	-1.0%	1.5%	5.9%	·	5.0%
ROIC	3.4%	11.7%	1.4%	1.3%	1.3%	0.38%	3.6%	0.84%	1.7%	4.5%	·	5.0%

Liquidität & Solvenz 5

Jährliche Liquidität & Solvenz-Daten für AORT
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	3.5	4.3	4.9	5.0	5.5	3.9	4.1	5.2	4.2	4.9	·	5.1
Quick Ratio	1.5	2.0	2.3	2.0	2.4	1.8	1.9	2.6	2.0	2.8	·	2.6
Debt / Equity	0.5	1.1	1.1	1.1	1.0	0.9	0.8	0.8	0.8	0.3	·	·
LT Debt / Equity	0.5	1.1	1.1	1.1	1.0	0.9	0.8	0.8	0.8	0.3	·	·
Interest Coverage	·	·	0.2	0.3	0.5	0.1	1.1	0.6	1.6	7.3	·	·

Effizienz 3

Jährliche Effizienz-Daten für AORT
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.5	0.5	0.4	0.4	0.4	0.5	0.5	0.4	0.7	·	0.8
Inventory Turnover	1.8	1.7	1.6	1.5	1.4	1.4	1.9	1.9	1.7	3.0	·	4.7
Receivables Turnover	5.2	5.1	5.3	5.5	6.0	5.1	5.5	5.6	5.0	7.0	·	7.4

Pro Aktie 7

Jährliche Pro Aktie-Daten für AORT
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$9.09	$6.36	$6.62	$6.80	$7.26	$8.14	$7.32	$7.15	$7.37	$6.11	·	$5.09
Revenue / Share	$9.36	$9.32	$8.69	$7.84	$7.67	$6.69	$7.30	$7.22	$5.55	$5.50	·	$5.11
Cash Flow / Share	$0.85	$0.53	$0.46	$-0.13	$-0.07	$0.33	$0.42	$0.27	$0.32	$0.60	·	$0.29
Cash / Share	$1.32	$1.23	$1.38	$0.94	$1.33	$1.52	$0.87	$1.08	$1.06	$1.65	·	$1.14
Dividend / Share	·	·	·	·	·	·	$0	$0	$0	$0	$0	$0
Dividend Paid / Share	·	·	·	·	·	·	·	·	·	·	$0	$0
EPS (TTM)	$0.21	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.32	$0.14	$0.25

Wachstumsraten 3

Jährliche Wachstumsraten-Daten für AORT
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	13.6%	9.8%	12.8%	5.0%	18.0%	·	·	·	·	·	·	·
Revenue CAGR 3Y	12.0%	9.1%	11.8%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	11.8%	·	·	·	·	·	·	·	·	·	·	·

Bewertung (TTM) 17

Jährliche Bewertung (TTM)-Daten für AORT
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$441M	$389M	$354M	$314M	$299M	$253M	$276M	$263M	$190M	$180M	$146M	$145M
Net Income TTM	$10M	$-13M	$-31M	$-19M	$-15M	$-17M	$2M	$-3M	$4M	$11M	$4M	$7M
Market Cap	$2.25B	$1.24B	$761M	$507M	$842M	$954M	$1.06B	$1.09B	$720M	$656M	·	$331M
Enterprise Value	$2.40B	$1.50B	$1.01B	$776M	$1.10B	$1.18B	$1.24B	$1.27B	$899M	$670M	·	·
P/E	217.2	-89.3	-23.8	-25.2	-53.6	-53.7	541.8	-354.8	174.1	59.8	77.0	45.3
P/S	5.1	3.2	2.2	1.6	2.8	3.8	3.8	4.2	3.8	3.6	·	2.3
P/B	5.0	4.5	2.7	1.8	2.8	2.9	3.7	4.0	2.6	3.1	·	2.2
P / Tangible Book	31.9	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	56.4	55.8	40.4	-98.4	-325.9	77.1	66.8	110.5	66.7	33.2	·	40.8
P / FCF	2681.7	112.4	66.8	-35.8	-53.7	189.2	136.3	266.6	172.7	48.5	·	87.0
EV / EBITDA	42.7	23.8	35.0	27.1	34.2	51.1	35.0	46.2	50.8	22.2	·	·
EV / FCF	2860.7	136.0	88.6	-54.7	-70.0	234.9	159.8	309.4	215.6	49.6	·	·
EV / Revenue	5.4	3.9	2.9	2.5	3.7	4.7	4.5	4.8	4.7	3.7	·	·
Dividend Yield	·	·	·	·	·	·	·	·	·	·	·	0.99%
Earnings Yield	0.46%	-1.1%	-4.2%	-4.0%	-1.9%	-1.9%	0.18%	-0.28%	0.57%	1.7%	1.3%	2.2%
Payout Ratio	·	·	·	·	·	·	·	·	·	·	·	45.0%
Annual Payout	·	·	·	·	·	·	·	·	·	·	$3M	$3M

Gewinn- und Verlustrechnung 18

Vierteljährliche Gewinn- und Verlustrechnung-Daten für AORT
Kennzahl	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$126M	$116M	$116M	$113M	$113M	$99M	$97M	$96M	$98M	$97M	$94M	$88M	$89M	$83M	$79M	$77M
Cost of Revenue	$45M	$41M	$43M	$39M	$40M	$35M	$36M	$35M	$35M	$34M	$33M	$32M	$31M	$30M	$29M	$28M
Gross Profit	$81M	$75M	$73M	$74M	$73M	$64M	$62M	$61M	$63M	$63M	$61M	$56M	$58M	$54M	$51M	$49M
R&D Expense	$9M	$9M	$9M	$8M	$7M	$7M	$7M	$7M	$7M	$7M	$8M	$6M	$7M	$7M	$8M	$12M
SG&A Expense	$80M	$61M	$57M	$57M	$58M	$55M	$51M	$50M	$49M	$31M	$50M	$51M	$57M	$50M	$38M	$41M
Operating Expenses	$89M	$70M	$66M	$65M	$65M	$61M	$59M	$57M	$57M	$38M	$58M	$58M	$65M	$58M	$47M	$53M
Operating Income	$-8M	$6M	$11M	$13M	$8M	$2M	$3M	$4M	$7M	$25M	$3M	$-1M	$8M	$-4M	$4M	$-4M
Interest Expense	·	·	·	·	·	·	·	·	·	$8M	·	$7M	$6M	$6M	·	$5M
Interest Income	$367.0K	$205.0K	$311.0K	$240.0K	$68.0K	$144.0K	$374.0K	$366.0K	$353.0K	$374.0K	$398.0K	$339.0K	$265.0K	$75.0K	$61.0K	$40.0K
Other Non-op	$4M	$-286.0K	$1M	$399.0K	$5M	$3M	$-10M	$2M	$-983.0K	$-1M	$2M	$-2M	$-4M	$963.0K	$4M	$-4M
Pretax Income	$-12M	$339.0K	$7M	$7M	$3M	$-2M	$-17M	$-1M	$-2M	$13M	$-591.0K	$-9M	$-3M	$-9M	$3M	$-13M
Income Tax	$2M	$-1M	$4M	$554.0K	$2M	$-2M	$-119.0K	$1M	$-306.0K	$5M	$3M	$382.0K	$725.0K	$5M	$1M	$1M
Net Income	$-14M	$1M	$2M	$7M	$1M	$-505.0K	$-16M	$-2M	$-2M	$8M	$-4M	$-10M	$-3M	$-14M	$2M	$-14M
EPS (Basic)	$-0.28	$0.03	$0.06	$0.14	$0.03	$-0.01	$-0.40	$-0.05	$-0.05	$0.18	$-0.10	$-0.24	$-0.08	$-0.33	$0.05	$-0.34
EPS (Diluted)	$-0.28	$0.03	$0.06	$0.13	$0.03	$-0.01	$-0.40	$-0.05	$-0.05	$0.18	$-0.10	$-0.24	$-0.08	$-0.33	$0.05	$-0.34
Shares (Basic)	48,541,000	48,074,000	-88,426,000	47,233,000	44,296,000	42,232,000	-83,141,000	41,844,000	41,683,000	41,290,000	-81,325,000	40,881,000	40,755,000	40,432,000	-79,964,000	40,115,000
Shares (Diluted)	48,541,000	49,731,000	-89,223,000	48,775,000	45,378,000	42,232,000	-89,737,000	41,844,000	41,683,000	47,886,000	-81,325,000	40,881,000	40,755,000	40,432,000	-79,964,000	40,115,000
EBITDA	$-8M	$12M	·	$13M	$8M	$8M	·	$4M	$7M	$31M	·	$-1M	$8M	$2M	·	$-4M

Bilanz 26

Vierteljährliche Bilanz-Daten für AORT
Kennzahl	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$77M	$56M	$65M	$73M	$53M	$38M	$53M	$56M	$55M	$51M	·	$53M	$49M	$31M	·	$38M
Receivables	$98M	$92M	$90M	$88M	$91M	$88M	$79M	$76M	$74M	$74M	·	$64M	$65M	$63M	·	$57M
Inventory	$103M	$98M	$92M	$91M	$87M	$82M	$80M	$84M	$81M	$82M	·	$79M	$78M	$76M	·	$73M
Prepaid Expense	$27M	$45M	$43M	$22M	$25M	$20M	$19M	$19M	$20M	$17M	·	$17M	$19M	$20M	·	$17M
Current Assets	$371M	$358M	$358M	$337M	$319M	$287M	$290M	$288M	$285M	$277M	·	$267M	$264M	$241M	·	$238M
PP&E (Net)	$74M	$68M	$65M	$41M	$40M	$38M	$36M	$38M	$37M	$38M	·	$37M	$38M	$39M	·	$36M
Goodwill	$350M	$252M	$254M	$254M	$254M	$245M	$241M	$249M	$244M	$245M	$247M	$243M	$246M	$246M	$244M	$235M
Intangibles	$149M	$120M	$124M	$126M	$129M	$128M	$128M	$135M	$135M	$138M	·	$143M	$147M	$150M	·	$148M
Other Non-current Assets	$15M	$16M	$15M	$29M	$27M	$25M	$24M	$21M	$14M	$13M	·	$8M	$8M	$8M	·	$7M
Total Assets	$1.07B	$883M	$885M	$858M	$838M	$791M	$789M	$803M	$790M	$784M	·	$775M	$778M	$757M	·	$743M
Accounts Payable	$21M	$18M	$16M	$16M	$19M	$12M	$18M	$11M	$12M	$10M	·	$11M	$10M	$9M	·	$11M
Accrued Liabilities	$16M	$17M	$16M	$12M	$11M	$12M	$12M	$16M	$16M	$16M	·	$10M	$10M	$10M	·	$10M
Current Liabilities	$107M	$93M	$102M	$86M	$67M	$52M	$67M	$153M	$51M	$46M	·	$55M	$56M	$44M	·	$46M
Capital Leases	$36M	$34M	$34M	$38M	$39M	$39M	$40M	$41M	$42M	$43M	·	$43M	$40M	$41M	·	$41M
Deferred Tax	$26M	$28M	$24M	$22M	$23M	$22M	$20M	$19M	$22M	$22M	·	$20M	$19M	$24M	·	$34M
Other Non-current Liabilities	$9M	$9M	$9M	$9M	$9M	$8M	$8M	$8M	$8M	$8M	·	$8M	$7M	$7M	·	$7M
Total Liabilities	$626M	$433M	$437M	$419M	$418M	$497M	$513M	$498M	$494M	$489M	·	$503M	$495M	$477M	·	$488M
Long-term Debt	$363M	$215M	$215M	$215M	$216M	$315M	$314M	$314M	$314M	$313M	·	$307M	$308M	$308M	·	$308M
Total Debt	$363M	$215M	·	$215M	$216M	$315M	·	$314M	$314M	$313M	·	$307M	$308M	$308M	·	$308M
Common Stock	$502.0K	$500.0K	$493.0K	$488.0K	$486.0K	$442.0K	$434.0K	$434.0K	$433.0K	$432.0K	·	$425.0K	$424.0K	$424.0K	·	$418.0K
Retained Earnings	$-64M	$-50M	$-51M	$-54M	$-60M	$-62M	$-61M	$-45M	$-42M	$-40M	·	$-44M	$-34M	$-31M	·	$-19M
Treasury Stock	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	·	$15M	$15M	$15M	·	$15M
AOCI	$-12M	$-12M	$-3M	$-2M	$-3M	$-19M	$-25M	$-10M	$-16M	$-14M	·	$-21M	$-16M	$-18M	·	$-45M
Stockholders' Equity	$446M	$450M	$448M	$439M	$420M	$294M	$276M	$305M	$295M	$295M	$282M	$272M	$283M	$280M	$284M	$255M
Liabilities + Equity	$1.07B	$883M	$885M	$858M	$838M	$791M	$789M	$803M	$790M	$784M	·	$775M	$778M	$757M	·	$743M
Shares Outstanding	50,179,000	49,983,000	49,330,000	48,862,000	48,592,000	44,190,000	43,432,000	43,392,000	·	·	42,569,000	42,537,000	42,443,000	42,366,000	41,830,000	41,816,000

Cashflow 16

Vierteljährliche Cashflow-Daten für AORT
Kennzahl	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$7M	$6M	$6M	$6M	$6M	$5M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$6M
Stock-based Comp	$8M	$8M	$4M	$6M	$6M	$8M	$3M	$4M	$4M	$3M	$4M	$3M	$4M	$3M	$3M	$3M
Deferred Tax	·	·	·	·	·	·	$3M	·	·	·	$6M	·	·	·	·	·
Amort. of Intangibles	$4M	$4M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M
Other Non-cash	·	$-15M	·	·	·	$-30M	·	·	·	$-22M	·	·	·	$-2M	·	·
Operating Cash Flow	$-1M	$1M	$20M	$22M	$15M	$-17M	$10M	$11M	$6M	$-5M	$11M	$7M	$7M	$-6M	$-217.0K	$4M
CapEx	$11M	$8M	$28M	$5M	$3M	$4M	$1M	$4M	$3M	$4M	$3M	$3M	$3M	$3M	$4M	$3M
Investing Cash Flow	$-129M	$-11M	$-31M	$-5M	$-3M	$-4M	$-11M	$-11M	$-3M	$-4M	$-3M	$-2M	$7M	$-3M	$-3M	$-3M
Debt Issued	·	·	$0	$0	$0	$0	$-6M	$160M	$160M	$190M	$0	$0	$0	$0	·	·
Net Debt Issued	·	$0	·	·	·	$-66.0K	·	·	·	$-182M	·	·	·	·	·	·
Stock Issued	$1M	$1M	$3M	$5M	$278.0K	$4M	$443.0K	$2M	$59.0K	$4M	$488.0K	$886.0K	$0	$3M	$24.0K	$1M
Net Stock Activity	·	$1M	·	·	·	$4M	·	·	·	$4M	·	·	·	$3M	·	·
Financing Cash Flow	$152M	$463.0K	$2M	$2M	$3M	$4M	$174.0K	$1M	$-181.0K	$737.0K	$-2M	$-909.0K	$2M	$1M	$-859.0K	$252.0K
Net Change in Cash	$22M	$-9M	$-9M	$20M	$16M	$-16M	$-3M	$1M	$4M	$-8M	$5M	$5M	$18M	$-9M	$2M	$-3M
Free Cash Flow	·	$-7M	·	·	·	$-21M	·	·	·	$-9M	·	·	·	$-8M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-14M	·	·	·	$-18M	·	·

Rentabilität 8

Vierteljährliche Rentabilität-Daten für AORT
Kennzahl	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	64.0%	64.8%	·	65.6%	64.7%	64.2%	·	63.7%	64.6%	64.6%	·	64.0%	65.1%	64.5%	·	63.4%
Operating Margin	-6.7%	5.0%	·	11.1%	7.4%	2.2%	·	4.6%	6.6%	26.0%	·	-1.4%	8.6%	-4.6%	·	-5.3%
Net Margin	-10.7%	1.2%	·	5.7%	1.2%	-0.51%	·	-2.4%	-2.2%	7.7%	·	-11.2%	-3.8%	-16.3%	·	-17.8%
Pretax Margin	-9.3%	0.29%	·	6.2%	3.1%	-2.3%	·	-1.3%	-2.5%	13.1%	·	-10.7%	-3.0%	-10.7%	·	-16.3%
EBITDA Margin	-6.7%	10.4%	·	11.1%	7.4%	7.7%	·	4.6%	6.6%	32.0%	·	-1.4%	8.6%	2.2%	·	-5.3%
ROA	-1.4%	0.17%	·	0.78%	0.17%	-0.06%	·	-0.29%	-0.27%	0.98%	·	-1.3%	-0.44%	-1.8%	·	-1.8%
ROE	-3.1%	0.38%	·	1.8%	0.38%	-0.17%	·	-0.79%	-0.73%	2.6%	·	-3.7%	-1.2%	-4.7%	·	-4.8%
ROIC	-1.2%	3.6%	·	1.8%	0.51%	0.08%	·	1.3%	0.93%	2.5%	·	-0.22%	1.7%	-1.0%	·	-0.80%

Liquidität & Solvenz 5

Vierteljährliche Liquidität & Solvenz-Daten für AORT
Kennzahl	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	3.5	3.9	·	3.9	4.8	5.5	·	1.9	5.6	6.0	·	4.9	4.7	5.5	·	5.2
Quick Ratio	1.6	1.6	·	1.9	2.2	2.4	·	0.9	2.5	2.7	·	2.1	2.0	2.1	·	2.1
Debt / Equity	0.8	0.5	·	0.5	0.5	1.1	·	1.0	1.1	1.1	·	1.1	1.1	1.1	·	1.2
LT Debt / Equity	0.8	0.5	·	0.5	0.5	1.1	·	0.7	1.1	1.1	·	1.1	1.1	1.1	·	1.2
Interest Coverage	·	·	·	·	·	·	·	·	·	3.2	·	-0.2	1.2	-0.6	·	-0.9

Effizienz 3

Vierteljährliche Effizienz-Daten für AORT
Kennzahl	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	0.5	0.5	·	0.4	0.5	0.4	·	0.4	0.4	0.4	·	0.4	0.4	0.4	·	0.4
Receivables Turnover	1.3	1.3	·	1.4	1.4	1.2	·	1.4	1.4	1.4	·	1.4	1.5	1.4	·	1.4

Pro Aktie 5

Vierteljährliche Pro Aktie-Daten für AORT
Kennzahl	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$8.88	$9.01	·	$8.98	$8.64	$6.66	·	$7.02	·	·	·	$6.39	$6.66	$6.61	·	$6.10
Revenue / Share	$2.59	$2.34	·	$2.32	$2.49	$2.34	·	$2.29	$2.35	$2.03	·	$2.15	$2.19	$2.06	·	$1.92
Cash Flow / Share	·	$0.02	·	·	·	$-0.40	·	·	·	$-0.11	·	·	·	$-0.15	·	·
Cash / Share	$1.54	$1.12	·	$1.50	$1.10	$0.85	·	$1.29	·	·	·	$1.26	$1.15	$0.73	·	$0.90
EPS (TTM)	$-0.09	$0.18	·	$0.10	$-0.08	$0.07	·	$-0.16	$-0.19	$-0.47	·	$-0.99	$-0.86	$-0.86	·	$-0.27

Bewertung (TTM) 14

Vierteljährliche Bewertung (TTM)-Daten für AORT
Kennzahl	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$468M	$442M	·	$421M	$406M	$390M	·	$379M	$373M	$358M	·	$337M	$330M	$318M	·	$307M
Net Income TTM	$-4M	$9M	·	$5M	$-4M	$3M	·	$-7M	$-8M	$-19M	·	$-40M	$-35M	$-35M	·	$-11M
Market Cap	$1.13B	$1.83B	·	$2.07B	$1.51B	$1.09B	·	$1.16B	·	·	·	$645M	$730M	$555M	·	$579M
Enterprise Value	$1.41B	$1.99B	·	$2.21B	$1.67B	$1.36B	·	$1.41B	·	·	·	$899M	$988M	$832M	·	$849M
P/E	-249.7	203.4	·	423.4	-388.8	351.1	·	-166.4	-135.0	-45.0	·	-15.3	-20.0	-15.2	·	-51.3
P/S	2.4	4.1	·	4.9	3.7	2.8	·	3.0	·	·	·	1.9	2.2	1.7	·	1.9
P/B	2.5	4.1	·	4.7	3.6	3.7	·	3.8	·	·	·	2.4	2.6	2.0	·	2.3
P / Tangible Book	·	23.2	·	35.5	41.0	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	·	1586.1	·	·	·	-64.1	·	·	·	·	·	·	·	-90.2	·	·
P / FCF	·	-267.2	·	·	·	-52.8	·	·	·	·	·	·	·	-66.1	·	·
EV / EBITDA	-169.0	164.1	·	176.3	199.6	179.6	·	322.1	·	·	·	-722.5	128.8	444.3	·	-206.9
EV / FCF	·	-290.5	·	·	·	-66.2	·	·	·	·	·	·	·	-99.2	·	·
EV / Revenue	3.0	4.5	·	5.2	4.1	3.5	·	3.7	·	·	·	2.7	3.0	2.6	·	2.8
Earnings Yield	-0.40%	0.49%	·	0.24%	-0.26%	0.28%	·	-0.60%	-0.74%	-2.2%	·	-6.5%	-5.0%	-6.6%	·	-1.9%

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Umsatz	$441M	$389M	$354M	$314M	$299M
Bruttogewinnmarge %	64.4%	64.0%	64.7%	64.5%	66.1%
Betriebsgewinnmarge %	7.6%	10.0%	1.6%	2.0%	2.7%
Nettoergebnis	$10M	$-13M	$-31M	$-19M	$-15M
Verwässerte EPS	$0.21	$-0.32	$-0.75	$-0.48	$-0.38

Bilanz

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Fremdkapital / Eigenkapital	0.5	1.1	1.1	1.1	1.0
Liquiditätsgrad	3.5	4.3	4.9	5.0	5.5
Quick Ratio	1.5	2.0	2.3	2.0	2.4

Cashflow

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Freier Cashflow	$839.0K	$11M	$11M	$-14M	$-16M

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Erstellung von Titeloptionen innerhalb redaktioneller Richtlinien: An ETF Shop hat ein abgestürztes Medtech zu seinem Top-Holding gemacht Nasdaq · 3 Monate vor
Starke Katalysatoren treiben Artivion (AORT) an Yahoo Finance · 3 Monate, 3 Wochen vor

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 217 Einreicher · $728.9M gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal

Neue Positionen	Geschlossene Positionen	Erhöht	Abgenommen	Nettoveränderung der Aktien
42 (+7 vs. Vorquartal)	64 (+28 vs. Vorquartal)	80 (-7 vs. Vorquartal)	47 (-16 vs. Vorquartal)	+5.4M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution	Wert	Aktien	% der verfolgten 13F	Typ
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$71.566.000	3.184.974	9,82%	Aktien
Juniper Investment Company, LLC	$45.386.816	2.019.885	6,23%	Aktien
VANGUARD CAPITAL MANAGEMENT LLC	$45.043.789	2.004.619	6,18%	Aktien
FMR LLC	$41.871.497	1.863.440	5,74%	Aktien
STATE STREET CORP	$41.750.406	1.858.051	5,73%	Aktien
Ophir Asset Management Pty Ltd	$40.446.180	1.800.008	5,55%	Aktien
PERCEPTIVE ADVISORS LLC	$39.036.906	1.737.290	5,36%	Aktien
Conestoga Capital Advisors, LLC	$36.484.539	1.623.700	5,01%	Aktien
SILVERCREST ASSET MANAGEMENT GROUP LLC	$23.011.325	1.024.091	3,16%	Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC	$22.205.281	988.219	3,05%	Aktien
GEODE CAPITAL MANAGEMENT, LLC	$21.427.261	953.365	2,94%	Aktien
DIMENSIONAL FUND ADVISORS LP	$20.062.856	892.873	2,75%	Aktien
CITADEL ADVISORS LLC	$17.701.821	787.798	2,43%	Aktien
YARGER WEALTH STRATEGIES, LLC	$15.278.432	634.223	2,10%	Aktien
ROYCE & ASSOCIATES LP	$14.364.667	639.282	1,97%	Aktien
WELLINGTON MANAGEMENT GROUP LLP	$11.702.264	520.795	1,61%	Aktien
Qube Research & Technologies Ltd	$10.704.820	476.405	1,47%	Aktien
FRED ALGER MANAGEMENT, LLC	$10.406.104	463.111	1,43%	Aktien
TWO SIGMA ADVISERS, LP	$9.974.907	218.700	1,37%	Aktien
D. E. Shaw & Co., Inc.	$9.846.714	438.216	1,35%	Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$9.183.579	408.704	1,26%	Aktien
Toroso Investments, LLC	$9.018.146	197.723	1,24%	Aktien
Soleus Capital Management, L.P.	$8.718.360	388.000	1,20%	Aktien
TWO SIGMA INVESTMENTS, LP	$8.702.159	387.279	1,19%	Aktien
Balyasny Asset Management L.P.	$8.584.686	382.051	1,18%	Aktien
GOLDMAN SACHS GROUP INC	$7.733.095	344.152	1,06%	Aktien
VANGUARD FIDUCIARY TRUST CO	$6.978.103	310.552	0,96%	Aktien
KENNEDY CAPITAL MANAGEMENT LLC	$6.611.371	294.231	0,91%	Aktien
UBS Group AG	$6.026.544	268.204	0,83%	Aktien
WASATCH ADVISORS LP	$5.726.929	156.388	0,79%	Aktien
BRIDGER MANAGEMENT, LLC	$4.855.373	132.588	0,67%	Aktien
Quantinno Capital Management LP	$4.497.191	200.142	0,62%	Aktien
AMERIPRISE FINANCIAL INC	$4.347.068	193.461	0,60%	Aktien
FIFTH THIRD BANCORP	$4.170.912	185.621	0,57%	Aktien
ORBIMED ADVISORS LLC	$3.932.250	175.000	0,54%	Aktien
Corient Private Wealth LP	$3.578.618	159.262	0,49%	Aktien
Public Sector Pension Investment Board	$3.298.304	146.787	0,45%	Aktien
Parkman Healthcare Partners LLC	$3.121.982	138.940	0,43%	Aktien
Universal- Beteiligungs- und Servicegesellschaft mbH	$2.879.149	128.133	0,40%	Aktien
VOLORIDGE INVESTMENT MANAGEMENT, LLC	$2.857.263	127.159	0,39%	Aktien
Summit Creek Advisors LLC	$2.704.354	120.354	0,37%	Aktien
CONNORS INVESTOR SERVICES INC	$2.700.445	120.180	0,37%	Aktien
BNP PARIBAS FINANCIAL MARKETS	$2.693.816	119.885	0,37%	Aktien
Bank of New York Mellon Corp	$2.522.415	112.257	0,35%	Aktien
RHUMBLINE ADVISERS	$2.373.280	105.621	0,33%	Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$2.303.872	102.531	0,32%	Aktien
XTX Topco Ltd	$2.173.905	96.747	0,30%	Aktien
Swiss National Bank	$1.914.444	85.200	0,26%	Aktien
BANK OF AMERICA CORP /DE/	$1.912.535	85.115	0,26%	Aktien
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	$1.875.420	51.213	0,26%	Aktien
LAZARD ASSET MANAGEMENT LLC	$1.875.301	83.458	0,26%	Aktien
RENAISSANCE TECHNOLOGIES LLC	$1.524.073	67.827	0,21%	Aktien
ALLIANCEBERNSTEIN L.P.	$1.522.477	41.575	0,21%	Aktien
Legal & General Group Plc	$1.468.954	65.374	0,20%	Aktien
CITIGROUP INC	$1.425.856	63.456	0,20%	Aktien
Squarepoint Ops LLC	$1.424.238	63.384	0,20%	Aktien
Russell Investments Group, Ltd.	$1.303.125	57.994	0,18%	Aktien
VICTORY CAPITAL MANAGEMENT INC	$1.193.157	53.100	0,16%	Aktien
ENVESTNET ASSET MANAGEMENT INC	$1.117.972	49.754	0,15%	Aktien
Sterling Capital Management LLC	$1.098.918	48.906	0,15%	Aktien
Sio Capital Management, LLC	$1.089.368	48.481	0,15%	Aktien
BOOTHBAY FUND MANAGEMENT, LLC	$1.010.521	44.972	0,14%	Aktien
PRUDENTIAL FINANCIAL INC	$995.219	44.291	0,14%	Aktien
WELLS FARGO & COMPANY/MN	$937.314	41.714	0,13%	Aktien
VANGUARD GROUP INC	$898.699	19.704	0,12%	Aktien
FIRST TRUST ADVISORS LP	$857.657	38.169	0,12%	Aktien
BlackRock, Inc.	$789.461	35.134	0,11%	Aktien
Zurcher Kantonalbank (Zurich Cantonalbank)	$738.274	32.856	0,10%	Aktien
Verition Fund Management LLC	$729.399	32.461	0,10%	Aktien
Aquatic Capital Management LLC	$712.771	31.721	0,10%	Aktien
Jain Global LLC	$680.908	30.303	0,09%	Aktien
JONES FINANCIAL COMPANIES LLLP	$662.072	28.042	0,09%	Aktien
Brevan Howard Capital Management LP	$652.461	29.037	0,09%	Aktien
VANGUARD ASSET MANAGEMENT, Ltd	$634.193	28.224	0,09%	Aktien
JANUS HENDERSON GROUP PLC	$623.335	17.038	0,09%	Aktien
MetLife Investment Management, LLC	$601.050	26.749	0,08%	Aktien
Y-Intercept (Hong Kong) Ltd	$600.735	26.735	0,08%	Aktien
Mariner, LLC	$570.520	25.390	0,08%	Aktien
TOCQUEVILLE ASSET MANAGEMENT L.P.	$561.750	25.000	0,08%	Aktien
Illinois Municipal Retirement Fund	$545.010	24.255	0,07%	Aktien
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$516.855	23.002	0,07%	Aktien
Walleye Capital LLC	$490.408	21.825	0,07%	Aktien
Penn Capital Management Company, LLC	$489.689	21.793	0,07%	Aktien
ALLSTATE CORP	$483.240	21.506	0,07%	Aktien
EXCHANGE TRADED CONCEPTS, LLC	$476.948	21.226	0,07%	Aktien
MORGAN STANLEY	$476.588	21.210	0,07%	Aktien
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$473.241	21.061	0,06%	Aktien
Louisiana State Employees Retirement System	$420.189	18.700	0,06%	Aktien
Invesco Ltd.	$409.628	18.230	0,06%	Aktien
DARK FOREST CAPITAL MANAGEMENT LP	$402.123	17.896	0,06%	Aktien
Vanguard Global Advisers, LLC	$371.384	16.528	0,05%	Aktien
Freestone Grove Partners LP	$328.219	14.607	0,05%	Aktien
NEW YORK STATE COMMON RETIREMENT FUND	$324.287	14.432	0,04%	Aktien
JOHNSON INVESTMENT COUNSEL INC	$307.008	13.663	0,04%	Aktien
Police & Firemen's Retirement System of New Jersey	$303.053	13.487	0,04%	Aktien
DIKER MANAGEMENT LLC	$303.000	13.500	0,04%	Aktien
OPPENHEIMER ASSET MANAGEMENT INC.	$284.672	12.669	0,04%	Aktien
GUGGENHEIM CAPITAL LLC	$283.302	12.608	0,04%	Aktien
ELEVATION POINT WEALTH PARTNERS, LLC	$263.303	11.718	0,04%	Aktien
Vestmark Advisory Solutions, Inc.	$263.303	11.718	0,04%	Aktien

Unternehmensinsider 49 Insider · 27 Führungskräfte · 15 Direktoren

Insider	Rolle	Letzte Aktivität	Gehaltene Aktien	Verkäufe 12m	Netto 12m
James P Mackin	President & CEO	6. März 2025 M	865.283	0	$0
David Ashley Lee	Executive VP, COO & CFO	2. März 2023 S	347.217	0	$0
Marshall S. Stanton	SVP, Clinical & MD Affair	17. Juni 2025 S	64.200	0	$0
John E Davis	Chief Commercial Officer	11. März 2025 M	208.778	0	$0
Amy Horton	VP, Chief Accounting Officer	6. März 2025 S	146.651	0	$0
Matthew A Getz	VP, Human Resources	16. August 2024 S	34.116	0	$0
Florian Tyrs	VP, Global Operations	27. Februar 2024 S	21.558	0	$0
Rochelle L. Maney	VP, Quality	26. Februar 2024 S	44.518	0	$0
Robert C Thomson	VP Research & Development	23. Februar 2024 A	13.291	0	$0
Dennis B Maier	SVP, Operations	6. Juni 2023 S	34.724	0	$0
Franz Peter Barthold	VP, Research & Development	8. November 2022 A	32.516	0	$0
Scott B Capps	VP, Clinical Research	12. März 2021 F	153.203	0	$0
James M Mcdermid	SVP, CHRO	14. März 2019 F	30.806	0	$0
Sherry M Saurini	VP, Quality	14. März 2019 F	25.084	0	$0
William Robert Matthews	Senior VP, Operations, Quality	5. März 2018 F	39.883	0	$0
David C Gale	VP, Research & Development	16. November 2017 M	77.135	0	$0
Steven G Anderson	Former Executive Chairman	9. April 2015 F	1.271.846	0	$0
Bruce G. Anderson	VP, US Sales &Global Marketing	7. März 2015 F	42.106	0	$0
FRONK DAVID	VP, Regulatory Affairs	7. März 2015 F	110.559	0	$0
David P. Lang	VP, Int'l Sales & Marketing	26. Februar 2015 A	73.441	0	$0
Jeffrey W Burris	Vice President & Gen. Counsel	15. August 2014 M	95.221	0	$0
Gerald B Seery	Sr. VP, Sales and Marketing	30. November 2012 S	71.999	0	$0
Albert E Heacox	Sr. VP Research and Devl	31. Dezember 2011 F	110.144	0	$0
Philip A Theodore	VP, General Counsel	4. September 2007 A	23.100	0	$0
Sidney B Ashmore	Vice President of Marketing	18. Januar 2006 M	42.728	0	$0
Kirby S Black	Sr. Vice President, R&D	21. September 2004 M	55.131	0	$0
Vander James C Wyk	VP - Product Integrity	14. September 2004 M	36.165	0	$0
Anthony B. Semedo	Direktor	2. Juni 2026 J	6.325	0	$0
Elizabeth A Hoff	Direktor	22. Mai 2025 A	31.389	0	$0
Marna P Borgstrom	Direktor	22. Mai 2025 A	49.088	0	$0
Jon W Salveson	Direktor	22. Mai 2025 A	129.840	0	$0
Jeffrey H Burbank	Direktor	22. Mai 2025 A	53.796	0	$0
Daniel J Bevevino	Direktor	22. Mai 2025 A	150.061	0	$0
Bullock James	Direktor	22. Mai 2025 A	68.647	0	$0
Thomas F Ackerman	Direktor	22. Mai 2025 A	149.896	0	$0
Harvey Morgan	Direktor	30. August 2021 G	46.342	0	$0
Ronald D Mccall	Direktor	25. August 2021 S	121.768	0	$0
Elkins C Ronald	Direktor	5. September 2018 S	64.843	0	$0
James Benson	Direktor	2. Oktober 2017 S	54.086	0	$0
John M Cook	Direktor	9. Juni 2009 M	85.000	0	$0
LACY VIRGINIA C	Direktor	24. April 2007 S	255.280	0	$0
VAN DYNE BRUCE J MD	Direktor	1. August 2006 A	12.800	0	$0
OSS CAPITAL MANAGEMENT	10%-Eigentümer	31. Mai 2007 S	1.918.000	0	$0
Lance A Berry	—	14. August 2026 S	210.112	1	$-20.413
Andrew M Green	—	14. August 2026 S	59.643	3	$-928.248
Jean F Holloway	—	12. August 2026 S	184.118	1	$-27.835
Michael S Simpson	—	5. März 2021 F	33.698	0	$0
Thomas J Bogenschuetz	—	5. Mai 2020 A	23.451	0	$0
Thomas J Lynch	—	2. November 2004 A	5.000	0	$0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 5 Beteiligungen

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder	Eingereicht	Beteiligung	Status	Zweck	Einreichung
Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 Einreichungen	12. August 2025	4,00%	Änderung	—	SEC
CryoLife, Inc., CL Falcon, Inc.	11. Mai 2011	—	Erste Einreichung	M&A / Verkauf	SEC
Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k)	10. Juli 2007	—	Erste Einreichung	—	SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter	2. Dezember 2005	—	Erste Einreichung	Passive Anlage	SEC
Nicht offengelegter meldender Beteiligter	18. März 2005	—	Erste Einreichung	Passive Anlage	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 53 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds	Gewicht	Anteile	Stand	Quelle
SAWS · ETF Series Solutions	2,95%	5.817 NS	30. April 2026	N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST	1,77%	26.421 NS	30. April 2026	N-PORT
PSCH · Invesco Exchange-Traded Fund Trust …	0,59%	37.075 SH	8. August 2026	Täglich
RZG · Invesco Exchange-Traded Fund Trust	0,44%	22.725 SH	8. August 2026	Täglich
SIXL · EXCHANGE TRADED CONCEPTS TRUST	0,25%	21.547 NS	31. Mai 2026	N-PORT
ESSC · Strategy Shares	0,24%	1.691 NS	30. April 2026	N-PORT
XSMO · Invesco Exchange-Traded Fund Trust	0,21%	246.008 SH	8. August 2026	Täglich
IHI · iShares Trust	0,16%	202.161 SH	8. August 2026	Täglich
IJT · iShares Trust	0,13%	397.869 SH	8. August 2026	Täglich
FYC · First Trust Exchange-Traded AlphaDE…	0,11%	31.285 NS	30. April 2026	N-PORT
VIOG · VANGUARD ADMIRAL FUNDS	0,10%	50.848 SH	8. August 2026	Täglich
QVMS · Invesco Exchange-Traded Fund Trust …	0,08%	7.285 SH	8. August 2026	Täglich
IWO · iShares Trust	0,08%	419.028 SH	8. August 2026	Täglich
XJR · iShares Trust	0,07%	5.059 SH	8. August 2026	Täglich
IJR · iShares Trust	0,06%	2.606.468 SH	8. August 2026	Täglich
VTWG · VANGUARD SCOTTSDALE FUNDS	0,06%	49.054 SH	8. August 2026	Täglich
VIOO · VANGUARD ADMIRAL FUNDS	0,05%	148.966 SH	8. August 2026	Täglich
RSSL · Global X Funds	0,05%	18.968 NS	30. April 2026	N-PORT
SAA · ProShares Trust	0,04%	505 NS	31. Mai 2026	N-PORT
DFAS · Dimensional ETF Trust	0,04%	158.121 NS	30. April 2026	N-PORT
IWM · iShares Trust	0,04%	1.162.604 SH	8. August 2026	Täglich
ISCG · iShares Trust	0,04%	14.407 SH	8. August 2026	Täglich
RWJ · Invesco Exchange-Traded Fund Trust …	0,04%	28.917 SH	8. August 2026	Täglich
GSSC · Goldman Sachs ETF Trust	0,03%	14.525 NS	31. Mai 2026	N-PORT
EBIT · Harbor ETF Trust	0,03%	101 NS	30. April 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,03%	263.046 SH	8. August 2026	Täglich
SMDX · Tidal Trust III	0,03%	999 NS	30. April 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,03%	27.103 SH	8. August 2026	Täglich
ITWO · ProShares Trust	0,02%	2.057 NS	31. Mai 2026	N-PORT
FHLC · FIDELITY COVINGTON TRUST	0,02%	18.392 NS	30. April 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,02%	2.917 NS	30. April 2026	N-PORT
SCHA · SCHWAB STRATEGIC TRUST	0,02%	200.917 NS	31. Mai 2026	N-PORT
ISCB · iShares Trust	0,02%	2.111 SH	8. August 2026	Täglich
UWM · ProShares Trust	0,01%	1.609 NS	31. Mai 2026	N-PORT
URTY · ProShares Trust	0,01%	1.624 NS	31. Mai 2026	N-PORT
JSTC · Tidal Trust I	0,01%	1.526 NS	31. Mai 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	495.296 SH	8. August 2026	Täglich
VHT · VANGUARD WORLD FUND	0,01%	127.662 SH	8. August 2026	Täglich
WSML · iShares Trust	0,01%	2.264 SH	8. August 2026	Täglich
DFAC · Dimensional ETF Trust	0,01%	107.410 NS	30. April 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,01%	1.773 NS	31. Mai 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	3.861 NS	30. April 2026	N-PORT
HDG · ProShares Trust	0,00%	41 NS	31. Mai 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	1.937 NS	30. April 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	8.873 NS	30. April 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	12.377 NS	30. April 2026	N-PORT
ITOT · iShares Trust	0,00%	61.883 SH	8. August 2026	Täglich
IWV · iShares Trust	0,00%	10.738 SH	8. August 2026	Täglich
SCHB · SCHWAB STRATEGIC TRUST	0,00%	25.635 NS	31. Mai 2026	N-PORT
TILT · FlexShares Trust	0,00%	636 NS	30. April 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	1.463.340 SH	8. August 2026	Täglich
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	3.652 SH	8. August 2026	Täglich
EBI · RBB Fund Trust	0,00%	3 NS	31. Mai 2026	N-PORT

Über Artivion, Inc. Common Stock Unternehmensübersicht von Wikipedia

AORT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

AORT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

Gleitende Durchschnitte und Überlagering

Volumen

Oszillatoren

Momentum und Trend

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

AORT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

12-Monats-Kursziel

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

Institutionelle Eigentümer (13F) 217 Einreicher · $728.9M gesamt · Stand 30. Juni 2026

Unternehmensinsider 49 Insider · 27 Führungskräfte · 15 Direktoren

Aktivisten & 5%+-Eigentümer 5 Beteiligungen

ETF-Besitz Gehalten von 53 ETFs